Literature DB >> 6392979

Gel tears. A new medication for the treatment of dry eyes.

H M Leibowitz, R K Chang, A I Mandell.   

Abstract

Gel Tears, a clear, semisolid formulation of synthetic, high molecular weight, cross-linked polymers of acrylic acid, persists in the conjunctival sac for hours after topical instillation, slowly melting while absorbing fluid and retaining it locally. In the present study of 55 patients (106 eyes) with severe dry eyes, who were unable to obtain ocular comfort with frequent administration of a wide variety of commercially available artificial tear preparations, 78% were improved by Gel Tear therapy. Subjective symptoms such as burning, stinging, foreign body sensation, dryness, and photophobia were significantly (P less than 0.001) alleviated, while objective signs concurrently improved but to a lesser degree. No patient required Gel Tears more often than four times daily. Most maintained optimal comfort on a dose of twice daily or less, and several patients previously unable to obtain ocular comfort with hourly administered conventional artificial tears required Gel Tears less than once a day.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392979     DOI: 10.1016/s0161-6420(84)34173-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells.

Authors:  Juan Ye; Huina Zhang; Han Wu; Changjun Wang; Xin Shi; Jiajun Xie; Jinjing He; Jun Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-24       Impact factor: 3.117

Review 2.  Therapeutic dilemmas in external ocular diseases.

Authors:  P A Asbell; M A Torres
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

3.  The palliative treatment of the dry eye.

Authors:  H J Völker-Dieben; C C Kok-van Alphen; J Hollander; P J Kruit; K Batenburg
Journal:  Doc Ophthalmol       Date:  1987 Sep-Oct       Impact factor: 2.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.